Description

Tirzepatide (rDNA Origin) for Injection 5 mg

Tirzepatide (rDNA origin) is an advanced, long-acting peptide therapy developed using recombinant DNA technology. It functions as a dual GIP and GLP-1 receptor agonist, offering a synergistic approach to metabolic control by targeting key hormonal pathways.

Mechanism of Action:
Tirzepatide enhances glucose-dependent insulin secretion, reduces glucagon levels, slows gastric emptying, and helps regulate appetite—supporting improved glycemic control and weight reduction.

Key Features:

• Dual incretin action (GIP + GLP-1) for enhanced efficacy
• Long-acting formulation for convenient once-weekly dosing
• 5 mg strength suitable for dose initiation or titration
• Manufactured using high-purity rDNA technology